TY - JOUR
T1 - Carcinoma tiroideo del epitelio folicular
T2 - Marcadores tumorales y oncogenes
AU - Álvarez-Núñez, Francisco
AU - Mora, Josefina
AU - Matías-Guiu, Xavier
AU - Bagué, Silvia
AU - de Leiva Hidalgo, Alberto
AU - Lerma, Enrique
AU - Martín-Campos, Jesus M.
AU - Rius, Xavier
AU - Rodriguez-Espinosa, José
AU - Vilar, Mónica
AU - Wagner, Ana
AU - Ybarra, Juan
PY - 2003/9/6
Y1 - 2003/9/6
N2 - Several genes control cell growth, differentiation and apoptosis. Any alteration in the sequence or expression of these genes can cause an uncontrolled growth of the tissue and produce a tumor. Quantitative and qualitative gene expression studies. using genes as tumor markers. are essential for the diagnosis and prognosis of the tumor and its behavior. Oncogenes are genes that stimulate cell growth and have an increased expression. On the contrary, tumor suppressor genes are genes that inhibit cell growth and have a decreased expression in tumor cells. To study these tumor markers we apply simple and random molecular biology techniques such as polymerase chain reaction (PCR), reverse transcription and genomic sequencing. In the case of thyroid epithelial neoplasia, tumor markers such as PTEN/MMAC1/TEP1, telomerase, RET/PTC, b-catenine, PAX8/PPAR(1, ciclooxygenase, thyroid stimulating hormonal receptor (TSHR), and thyroglobulin are being investigated. These markers are analized for somatic mutations in the genetic sequence, cromosomical rearrangements, alterations in the promoter zone that affect gene expression, regulation and studies of genes at mRNA level. A deeper study of these markers is deemed to help improve the accuracy of tumor diagnosis, behavior and prognosis. Hence, more effective therapeutic options will be adapted to each individual, eventually reducing hospital costs.
AB - Several genes control cell growth, differentiation and apoptosis. Any alteration in the sequence or expression of these genes can cause an uncontrolled growth of the tissue and produce a tumor. Quantitative and qualitative gene expression studies. using genes as tumor markers. are essential for the diagnosis and prognosis of the tumor and its behavior. Oncogenes are genes that stimulate cell growth and have an increased expression. On the contrary, tumor suppressor genes are genes that inhibit cell growth and have a decreased expression in tumor cells. To study these tumor markers we apply simple and random molecular biology techniques such as polymerase chain reaction (PCR), reverse transcription and genomic sequencing. In the case of thyroid epithelial neoplasia, tumor markers such as PTEN/MMAC1/TEP1, telomerase, RET/PTC, b-catenine, PAX8/PPAR(1, ciclooxygenase, thyroid stimulating hormonal receptor (TSHR), and thyroglobulin are being investigated. These markers are analized for somatic mutations in the genetic sequence, cromosomical rearrangements, alterations in the promoter zone that affect gene expression, regulation and studies of genes at mRNA level. A deeper study of these markers is deemed to help improve the accuracy of tumor diagnosis, behavior and prognosis. Hence, more effective therapeutic options will be adapted to each individual, eventually reducing hospital costs.
KW - Differentiated thyroid carcinomas
KW - Gen sequence
KW - Polymerase chain reaction
KW - Reverse transcription
KW - Tumor markers
UR - https://www.scopus.com/pages/publications/0141669243
U2 - 10.1157/13050439
DO - 10.1157/13050439
M3 - Artículo de revisión
C2 - 12975039
AN - SCOPUS:0141669243
SN - 0025-7753
VL - 121
SP - 264
EP - 269
JO - Medicina clinica
JF - Medicina clinica
IS - 7
ER -